Clostridium difficile infection (CDI) is one of the most common healthcare-associated infections, causing significant morbidity and mortality, increased healthcare costs, and prolonged hospital lengths of stay. [1] [2] [3] Published reports indicate that the incidence and severity of CDI are increasing. [4] [5] [6] The emergence of a hypervirulent epidemic strain and community-acquired disease in patients who were previously considered to be at low risk will likely place an even greater burden on patients and the healthcare system. [7] [8] [9] Subtotal colectomy with end ileostomy is the treatment of choice for patients with fulminant CDI refractory to medical therapy. [10] [11] [12] [13] [14] [15] Studies have identified a variety of factors associated with improved survival after CDI-related colectomy, and colectomy performed earlier in the course of fulminant colitis, before the patient becomes critically ill, is generally associated with improved survival. 10, 11, 13, [15] [16] [17] [18] Studies have reported colectomy rates for CDI from less than 1% to 3% of CDI cases, 9, 11, [14] [15] [16] [17] [18] [19] [20] and the rate of colectomies for severe disease appears to be rising over time. 21 These studies have been limited to single centers or outbreak settings, so little is known about overall temporal trends in colectomy rates in nonoutbreak settings. Furthermore, the relationship between the location of CDI symptom onset and the risk of colectomy for CDI is unknown.
The objective of this study was to conduct a multicenter, multiyear analysis of the incidence of colectomies for severe CDI in a nonoutbreak setting. Colectomy cases were further classified by the location of CDI onset, on the basis of published recommended surveillance definitions.
methods

Setting and Population
Five geographically diverse academic hospitals participating in the Prevention Epicenters Program of the Centers for Disease Control and Prevention collected inpatient data from Patient's stool sample tested positive ≤48 hours after admission, provided that symptom onset was !4 weeks after the last discharge from a HCF and the most recent discharge was from an Epicenter Community onset, non-study-hospital associated
Patient's stool sample tested positive ≤48 hours after admission, provided that symptom onset was !4 weeks after the last discharge from a HCF and the most recent discharge was from a HCF other than an Epicenter Community onset, community associated
Patient's stool sample tested positive ≤48 hours after admission, provided that 112 weeks have elapsed since the last discharge from a HCF Indeterminate Patient's exposure setting does not fit any of the other criteria (eg, positive stool sample ≤48 hours after admission with HCF exposure 4-12 weeks prior to sample collection) Recurrent
Patient's stool sample tested positive ≤8 weeks after a prior positive stool sample Unknown Patient's exposure setting could not be determined because of lack of available data note. HCF, healthcare facility. To provide a description of the overall population at the 5 hospitals, 4 patients not diagnosed with CDI were randomly selected among the patients discharged from the same study hospital during the same year for every case of CDI identified by toxin assay results or ICD-9-CM codes.
Definitions
The charts of all patients with a positive assay for C. difficile or the ICD-9-CM diagnosis code for CDI and an ICD-9-CM procedure code for colectomy were reviewed to determine if the colectomy was for CDI (CDI-related colectomy). For patients without a colectomy, a case of CDI was defined as a positive C. difficile stool toxin assay. For patients with CDIrelated colectomy, a case of CDI was defined as the presence of a positive C. difficile toxin assay or the presence of the ICD-9-CM code for CDI and a CDI-related colectomy. The reason to have different definitions for a case of CDI based on whether there was a colectomy for CDI is 2-fold. All study hospitals are academic medical centers. Patients may be transferred for severe CDI and proceed to colectomy without repeating a toxin assay. In addition, patients with fulminant CDI may have an ileus or be taken to surgery prior to procurement of stool for C. difficile testing. Therefore, it was determined that the charts of patients assigned the ICD-9-CM code for CDI and a procedure code for colectomy would be reviewed. Conversely, most patients assigned the ICD-9-CM code for CDI without a positive toxin assay do not have CDI on the basis of further chart review. 22 Because of this, it was determined to be unnecessary to review the charts of the approximately 3,000 patients who were assigned the ICD-9-CM code for CDI but who did not have a positive toxin assay or a colectomy.
Cases of CDI were categorized on the basis of published surveillance definitions. 4, [23] [24] [25] Charts of all patients with CDI onset 48 hours or less from admission were reviewed to determine recent healthcare exposures. Cases were categorized as healthcare facility (HCF) onset; community onset, studyhospital associated; community onset, non-study-hospital associated; indeterminate; and recurrent (Table 1) . Recurrent cases were cases of CDI with a history of a positive toxin assay within the previous 8 weeks.
Data Analysis
Colectomy rates were calculated as the number of CDI-related colectomies per 1,000 toxin-positive cases. Data from hospital E were incomplete for the first 14 months; these months for hospital E were excluded from the analysis. Composite Charlson scores were calculated to assess comorbidity. 26 All tests were 2-tailed, and a P value of less than .05 was considered statistically significant, with Bonferroni adjustments for multiple comparisons when applicable. Data were compared with x 2 , x 2 for trend, Fisher exact, and Mann-Whitney U tests. Univariate logistic regression was used to examine the contributions of age, sex, race, location of onset, Charlson score, and study center to the risk of colectomy. Variables associated with colectomy in unadjusted analysis ( ) were included P ! .05 in a multivariable regression logistic model to identify independent predictors of colectomy. Stepwise backward lo- cases of recurrent CDI. There were 252 patients who had a positive toxin assay or who were assigned the ICD-9-CM code for CDI and underwent a colectomy during the same hospitalization. Seventy-five (29.8%) of these patients had a CDIrelated colectomy. Forty-nine patients (65%) with CDIrelated colectomy had a documented positive toxin assay during the same admission. The colectomy incidence over the entire study period was 8.7 CDI-related colectomies per 1,000 CDI episodes. There was no significant overall trend in the annual incidence of CDI-related colectomy during the study period. Demographic data are provided in Table 2 . Overall, patients with CDI were older ( ) and had higher Charlson scores P ! .05 than patients without CDI ( ). The median age of pa-P ! .05 tients who had a CDI-related colectomy was higher than that of patients with CDI who did not have a colectomy (68.2 vs 61.5 years;
). White patients made up 71% of toxin-P p .03 positive CDI cases but 83% of patients who had a CDI-related colectomy (
). The proportion of colectomy patients P p .03 who were female was 43%, compared with 50% of patients with a CDI-related colectomy (
). The population of P p .23 patients who underwent a CDI-related colectomy had lower Charlson scores than patients with CDI who did not undergo colectomy ( ). P p .04 Colectomy incidence at each hospital during the study period ranged from 0 to 23 per 1,000 CDI episodes. The only hospital with a significant linear trend in the annual colectomy rate over time was hospital A, which had an increase in CDI-related colectomy during the study period ( ; P p .01 Figure 1 ). Though annual variations were evident, particularly at hospitals C and D, there were likely too few colectomies to find a significant linear trend. No colectomies for CDI were reported at hospital E during the study period. Comparisons by study center are presented in Table 2 . Among patients without CDI, those at hospital A were the oldest, and those at hospital B were the youngest (55 vs 47 years;
). Patients at hospital C had the highest Charlson P ! .001 comorbidity scores, and those at hospital E had the lowest (1.6 vs 0.5;
). Among patients with CDI who did not P ! .001 undergo colectomy, those at hospital C were the oldest (66 years) and had the highest Charlson scores (2.5), whereas those at hospital E were the youngest (51 years) and had the lowest Charlson scores (0.7; both ). Patients with P ! .001 CDI-related colectomy were the oldest (70 years) at hospital D and the youngest at hospital B (42 years;
, not P p .02 significant after Bonferroni correction). Those who had CDIrelated colectomy at hospital D had the lowest Charlson scores, and those at hospital C had the highest scores (0.6 vs 2.2;
). P p .01 HCF-onset CDI represented 4,897 episodes of CDI (58% of all toxin-positive episodes; Table 3 ). There were 21 CDI-related colectomies for HCF-onset CDI, accounting for 29% of all CDI-related colectomies. There were 794 episodes of community-onset, study-hospital-associated CDI (9% of all episodes) and 10 CDI-related colectomies (13% of CDI-related colectomy). The community-onset, non-study-hospital-associated category included 1,063 episodes of CDI (12% of all episodes) and 23 CDI-related colectomies (31% of CDI-related colectomies). There were 520 episodes of community-associated CDI (6% of all episodes) and 5 CDI-related colectomies (7% of CDI-related colectomies). Community-onset cases had higher colectomy rates than hospital-onset cases at all 4 hospitals that reported colectomies during the study period ( Figure figure 2 . Clostridium difficile infection (CDI)-related colectomy rates by location of symptom onset. HCF, healthcare facility.
2). Six percent of cases and 4% of colectomies occurred among patients with recurrent CDI.
Risk factors for CDI-related colectomy are presented in Table 4 . Advanced age (65 years and older) was associated with colectomy, with an OR of 1.9 ( ). White patients P ! .05 had a significantly higher OR for colectomy than nonwhite patients (OR, 2.0;
). Admission to hospitals C and D P p .02 was also associated with more CDI-related colectomies (
). There were no differences in the risk of colectomy 
discussion
This study examined CDI-related colectomy rates at multiple HCFs over a 6-year period. We also assessed risk factors associated with CDI-related colectomy. Prior studies of colectomy for CDI have been limited by being conducted at single centers, over relatively brief periods of time, or in response to CDI outbreaks. These studies have potentially biased the literature to more severe outbreaks of CDI. Our study minimizes these biases by including multiple HCFs over several years in the absence of any sudden increases in CDI incidence or clinically apparent increases in deaths due to CDI. 4 CDI-related colectomy rates in the literature differ based on the clinical setting, drawing from a wide variety of patient populations and CDI rates. The overall CDI-related colectomy rate in this study was 8.7 per 1,000 CDI cases, consistent with previously published rates, which ranged from 2.7 to 32 colectomies per 1,000 CDI cases. 9, 11, [14] [15] [16] [17] [18] [19] [20] Kutty et al 9 recently published a report of a community-based CDI outbreak in 6 hospitals in North Carolina involving 109 patients with CDI; none required intensive care unit admission or a colectomy. It was hypothesized that the paucity of severe cases was due to the young age of the study population (median, 62 years). In contrast, Lamontagne et al 13 found that 23% of the 165 patients in 2 hospitals' intensive care units with fulminant colitis required a colectomy. The hospitalized population in our study includes low-and high-acuity patients, and the colectomy rate fell between those 2 extremes.
There are few published data describing colectomy rates according to CDI surveillance definitions. One single-center study during an outbreak at a community hospital reported a colectomy incidence for HCF-onset CDI of 2%. 19 The HCFonset colectomy rate in our study was lower, at 0.43%. We found that patients who had community-onset CDI with recent HCF exposure had the highest colectomy rate (Table 3) . To our knowledge, there are no prior studies of colectomy incidence among community-onset cases that can be used for comparison. The colectomy rate among patients with community-onset CDI in this study may be biased high. Four of the 5 study hospitals are academic referral centers. It is not uncommon for patients with severe CDI to be transferred for management of severe CDI and possible colectomy.
There are no standard guidelines for selecting patients with CDI for colectomy, and this may account for the differences in CDI-related colectomy rates across the study hospitals. Some patterns did emerge. Overall, patients who underwent CDI-related colectomy were significantly older than patients with CDI who did not have a colectomy. This age difference was present at all centers and likely reflects the higher likelihood of older patients developing severe CDI. 6, 20, 27 Patients who had a CDI-related colectomy had lower Charlson scores than patients with CDI who did not have a colectomy. This may reflect a greater willingness to proceed to colectomy among patients with fewer comorbidities, who are more likely to survive an emergent, high-risk procedure. Patients were more likely to have a colectomy for CDI at hospitals C and D. At these particular centers, there were no obvious associations between mortality of patients without CDI and either mortality of patients with CDI or CDI-related colectomy rates. Data on treatment for CDI was not collected. Therefore, it is not possible to determine whether differences in CDIrelated colectomy rates translated to improved patient outcomes.
This study has some limitations. Different case definitions were used for the numerator and denominator to determine the rate of CDI-related colectomy. When conducting surveillance for a rare event, missing a few cases may result in large differences in the identified disease incidence. On the other hand, missing a few noncases has less of an impact on the identified disease incidence. These factors must be considered when balancing the accuracy of the method of surveillance with the resources necessary to conduct the surveillance. Use of ICD-9-CM codes to identify patients with CDI has been shown to overestimate the number of cases of CDI, and most patients with the ICD-9-CM code for CDI but without a corresponding positive toxin assay do not have CDI. Although ICD-9-CM codes are specific for CDI, the positive predictive value is only approximately 75% because of the relatively low prevalence of CDI. 22 Therefore, it was decided to limit the CDI-without-colectomy group to CDI cases with positive toxin assays only. Conversely, there was concern that some patients with CDI diagnosed at a referring HCF would be transferred for severe CDI and proceed to colectomy without repeating a toxin assay at the study hospital or that patients with fulminant CDI may be taken to surgery prior to procurement of a stool specimen for toxin testing. Although these cases represent a minority of all CDI cases, they may represent a large proportion of patients who undergo a CDI-related colectomy. These patients were included in the definition of CDI-related colectomy to avoid missing these cases. Consequently, colectomy rates may be overestimated, particularly for community-onset, non-studyhospital-associated cases. This is notable considering the overall low incidence of colectomy identified in this study.
As reported previously, 4 hospital B experienced a CDI pseudo-outbreak from July 1, 2004 , to June 30, 2006, related to improper stool sample collection and transport. We chose to include data from hospital B during the pseudo-outbreak for this particular study, since 2 of the 4 colectomies performed during the study period at hospital B were performed during the pseudo-outbreak. The true colectomy incidence during these periods is therefore likely biased low. Another limitation of the data is that different toxin assays were used among the hospitals over the study period. It is unclear how or to what extent these different assays may have influenced CDI incidence. Additionally, data on infecting C. difficile strains are not available. It is possible that the hospitals involved in this study have a low proportion of CDI cases due to highly virulent epidemic strains, thus accounting for the low colectomy incidence. The epidemic BI/NAP1/027 strain has been identified at hospital A.
This study reports that no significant change in overall colectomy rates occurred from 2000 to 2006 but that CDIrelated colectomy is associated with community-onset CDI, there are differences in colectomy incidence across HCFs without an obvious impact on outcome, and CDI-related colectomy is associated with high mortality. Because of the difficulties in establishing optimal criteria on when to take a patient with CDI to surgery, our study supports the need for prospective surveillance studies to track CDI-related colec-tomy trends in stable sentinel populations while using standardized case definitions. Studies such as these will allow for comparisons between HCFs to identify trends in CDI-related colectomies and factors associated with improved patient outcomes, which can be used to improve patient selection for CDI-related colectomy.
